Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 71

1.

Allocation of Donor Livers for Transplantation: A Contemporary Struggle.

Gerber DA, Baliga P, Karp SJ.

JAMA Surg. 2018 Jun 20. doi: 10.1001/jamasurg.2018.1519. [Epub ahead of print] No abstract available.

PMID:
29926088
2.

Directed solutions to address differences in access to liver transplantation.

Ye F, Sheng Q, Feurer ID, Zhao Z, Fan R, Teng J, Ping J, Rega SA, Hanto DW, Shyr Y, Karp SJ.

Am J Transplant. 2018 Apr 24. doi: 10.1111/ajt.14889. [Epub ahead of print]

PMID:
29689125
3.

Intensive Care Unit Enhanced Recovery Pathway for Patients Undergoing Orthotopic Liver Transplants Recipients: A Prospective, Observational Study.

King AB, Kensinger CD, Shi Y, Shotwell MS, Karp SJ, Pandharipande PP, Wright JK, Weavind LM.

Anesth Analg. 2018 May;126(5):1495-1503. doi: 10.1213/ANE.0000000000002851.

PMID:
29438158
4.

An Outcome-Based Approach to Assign MELD Exception Points for Patients With Hepatocellular Cancer.

Kensinger CD, Feurer ID, Karp SJ.

Transplantation. 2017 Sep;101(9):2056-2061. doi: 10.1097/TP.0000000000001812.

PMID:
28471871
5.

Retroversus Implantation of a Situs Solitus Deceased Donor Liver into a Situs Inversus Totalis Recipient.

Kauffmann R, Karp SJ, Wright JK, Geevarghese SK.

Am Surg. 2017 Apr 1;83(4):e120-122. No abstract available.

PMID:
28424114
6.

Dicer-dependent production of microRNA221 in hepatocytes inhibits p27 and is required for liver regeneration in mice.

Oya Y, Masuzaki R, Tsugawa D, Ray KC, Dou Y, Karp SJ.

Am J Physiol Gastrointest Liver Physiol. 2017 May 1;312(5):G464-G473. doi: 10.1152/ajpgi.00383.2016. Epub 2017 Feb 23.

7.

Netrin-1: Needed Help for Throughput in the ER in Patients With Liver Disease.

Karp SJ.

Cell Mol Gastroenterol Hepatol. 2016 Mar 24;2(3):255. doi: 10.1016/j.jcmgh.2016.02.006. eCollection 2016 May. No abstract available.

8.

Interpreting Outcomes in DCDD Liver Transplantation: First Report of the Multicenter IDOL Consortium.

Goldberg DS, Karp SJ, McCauley ME, Markmann JF, Croome KP, Taner CB, Heimbach JK, Leise MD, Fryer JP, Bohorquez HE, Cohen AJ, Gilroy RK, Kumer SC, Foley DP, Karim AS, Hernandez-Alejandro R, Levstik MA, Abt PL.

Transplantation. 2017 May;101(5):1067-1073. doi: 10.1097/TP.0000000000001656.

PMID:
28114173
9.

Cytometry-based single-cell analysis of intact epithelial signaling reveals MAPK activation divergent from TNF-α-induced apoptosis in vivo.

Simmons AJ, Banerjee A, McKinley ET, Scurrah CR, Herring CA, Gewin LS, Masuzaki R, Karp SJ, Franklin JL, Gerdes MJ, Irish JM, Coffey RJ, Lau KS.

Mol Syst Biol. 2016 Aug 29;12(8):881. doi: 10.15252/msb.20167270. No abstract available.

10.

NAFLD as a risk factor for HCC: new rules of engagement?

Masuzaki R, Karp SJ, Omata M.

Hepatol Int. 2016 Jul;10(4):533-4. doi: 10.1007/s12072-016-9731-8. Epub 2016 May 5. No abstract available.

11.

SOCS2 Balances Metabolic and Restorative Requirements during Liver Regeneration.

Masuzaki R, Zhao S, Valerius MT, Tsugawa D, Oya Y, Ray KC, Karp SJ.

J Biol Chem. 2016 Feb 12;291(7):3346-58. doi: 10.1074/jbc.M115.703264. Epub 2015 Dec 23.

12.

Cytometry-based single-cell analysis of intact epithelial signaling reveals MAPK activation divergent from TNF-α-induced apoptosis in vivo.

Simmons AJ, Banerjee A, McKinley ET, Scurrah CR, Herring CA, Gewin LS, Masuzaki R, Karp SJ, Franklin JL, Gerdes MJ, Irish JM, Coffey RJ, Lau KS.

Mol Syst Biol. 2015 Oct 30;11(10):835. doi: 10.15252/msb.20156282. Erratum in: Mol Syst Biol. 2016 Aug 29;12(8):881.

13.

A Role for Extracellular Vesicles in Liver Fibrosis.

Karp SJ.

Cell Mol Gastroenterol Hepatol. 2015 Sep 25;1(6):572-573. doi: 10.1016/j.jcmgh.2015.09.003. eCollection 2015 Nov. No abstract available.

14.

Biology of hepatocyte regeneration in acute liver failure.

Karp SJ.

Liver Transpl. 2015 Nov;21 Suppl 1:S34-5. doi: 10.1002/lt.24320. No abstract available.

15.

Functional Implications of Biochemical and Molecular Characteristics of Donation After Circulatory Death Livers.

Masuzaki R, Yu H, Kingsley P, Marnett L, Zhao Z, Karp SJ.

Transplant Direct. 2015 Jun 15;1(5):e18. doi: 10.1097/TXD.0000000000000527. eCollection 2015 Jun.

16.

Specific activin receptor-like kinase 3 inhibitors enhance liver regeneration.

Tsugawa D, Oya Y, Masuzaki R, Ray K, Engers DW, Dib M, Do N, Kuramitsu K, Ho K, Frist A, Yu PB, Bloch KD, Lindsley CW, Hopkins CR, Hong CC, Karp SJ.

J Pharmacol Exp Ther. 2014 Dec;351(3):549-58. doi: 10.1124/jpet.114.216903. Epub 2014 Sep 30.

17.

Renal transplantation in the setting of early steroid withdrawal: a comparison of rabbit antithymocyte globulin induction dosing in two eras.

Rogers CC, Asipenko N, Horwedel T, Gautam S, Goldfarb-Rumyantzev AS, Pavlakis M, Johnson SR, Karp SJ, Evenson A, Khwaja K, Hanto DW, Mandelbrot DA.

Am J Nephrol. 2013;38(5):397-404. doi: 10.1159/000355620. Epub 2013 Oct 26.

PMID:
24192457
18.

CD39 modulates hematopoietic stem cell recruitment and promotes liver regeneration in mice and humans after partial hepatectomy.

Schmelzle M, Duhme C, Junger W, Salhanick SD, Chen Y, Wu Y, Toxavidis V, Csizmadia E, Han L, Bian S, Fürst G, Nowak M, Karp SJ, Knoefel WT, Esch JSA, Robson SC.

Ann Surg. 2013 Apr;257(4):693-701. doi: 10.1097/SLA.0b013e31826c3ec2.

19.

Scar formation and lack of regeneration in adult and neonatal liver after stromal injury.

Masuzaki R, Zhao SR, Csizmadia E, Yannas I, Karp SJ.

Wound Repair Regen. 2013 Jan-Feb;21(1):122-30. doi: 10.1111/j.1524-475X.2012.00868.x. Epub 2012 Dec 10.

PMID:
23228176
20.

BMP4 is a novel paracrine inhibitor of liver regeneration.

Do N, Zhao R, Ray K, Ho K, Dib M, Ren X, Kuzontkoski P, Terwilliger E, Karp SJ.

Am J Physiol Gastrointest Liver Physiol. 2012 Dec 1;303(11):G1220-7. doi: 10.1152/ajpgi.00105.2012. Epub 2012 Sep 27.

Supplemental Content

Support Center